Zdrowie i gospodarka · 03/09/2024
FDA Classifies Digital Therapy Device for Attention Deficit Hyperactivity Disorder into Class II Special Controls
The FDA has classified the digital therapy device for Attention Deficit Hyperactivity Disorder into Class II special controls, aiming to ensure the device's safety and effectiveness while enhancing patients' access to innovative treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →